455
Views
64
CrossRef citations to date
0
Altmetric
Research Article

Angiogenesis-related gene expression profiling in ventilated preterm human lungs

, &
Pages 399-410 | Received 13 Dec 2009, Accepted 15 Feb 2010, Published online: 18 Aug 2010

REFERENCES

  • Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–1729.
  • Husain AN, Siddiqui NH, Stocker JT: Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29:710–717.
  • Coalson JJ: Pathology of chronic lung disease in early infancy. In: Bland RD, Coalson JJ, eds. Chronic Lung Disease in Early Infancy. New York: M. Dekker; 2000:85– 124
  • Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM: Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;164:1971–1980.
  • De Paepe ME, Mao Q, Powell J, Rubin SE, DeKoninck P, Appel N, Dixon M, Gundogan F: Growth of pulmonary microvasculature in ventilated preterm infants. Am J Respir Crit Care Med. 2006;173:204–211.
  • Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA: Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med. 1999;160:1333–1346.
  • Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H: Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol. 2002;282:L811–L823.
  • Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH: Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol. 2000;279:L600–L607.
  • Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH: Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol. 2002;283:L555–L562.
  • Abman SH: Bronchopulmonary dysplasia: “a vascular hypothesis.” Am J Respir Crit Care Med. 2001;164:1755–1756.
  • Thebaud B, Abman SH: Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med. 2007;175:978–985.
  • Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–395.
  • Adams RH, Alitalo K: Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8:464–478.
  • De Paepe ME, Patel C, Tsai A, Gundavarapu S, Mao Q: Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants. Am J Respir Crit Care Med. 2008;178:180–187.
  • De Paepe ME: Lung growth and development. In: Churg AM, Myers JL, Tazelaar HD, Wright JL, eds. Thurlbeck's Pathology of the Lung. New York: Thieme Medical Publishers; 2005; pp. 39–84.
  • De Paepe ME, Friedman RM, Gundogan F, Pinar H: Postmortem lung weight/body weight standards for term and preterm infants. Pediatr Pulmonol. 2005;40:445–448.
  • De Paepe ME, Mao Q, Huang C, Zhu D, Jackson CL, Hansen K: Postmortem RNA and protein stability in perinatal human lungs. Diagn Mol Pathol. 2002;11:170–176.
  • Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.
  • Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587–597.
  • Stahlman MT, Orth DN, Gray ME: Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate. Lab Invest. 1989;60:539–547.
  • Strandjord TP, Clark JG, Guralnick DE, Madtes DK: Immunolocalization of transforming growth factor-alpha, epidermal growth factor (EGF), and EGF-receptor in normal and injured developing human lung. Pediatr Res. 1995;38:851–856.
  • Gougos A, Letarte M: Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol. 1988;141:1925–1933.
  • Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C: Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem. 2002;277:43799–43808.
  • Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP: Defective angiogenesis in mice lacking endoglin. Science. 1999;284:1534–1537.
  • Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, Burn J, Diamond AG: Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol. 2000;217:42–53.
  • Adams JC: Thrombospondin-1. Int J Biochem Cell Biol. 1997;29:861–865.
  • O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277–285.
  • Abdollahi A, Hahnfeldt P, Maercker C, Grone HJ, Debus J, Ansorge W, Folkman J, Hlatky L, Huber PE: Endostatin's antiangiogenic signaling network. Mol Cell. 2004;13:649–663.
  • Ryu J, Vicencio AG, Yeager ME, Kashgarian M, Haddad GG, Eickelberg O: Differential expression of matrix metalloproteinases and their inhibitors in human and mouse lung development. Thromb Haemost. 2005;94:175–183.
  • Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL: Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 1985;24:5480–5486.
  • Pavlov N, Badet J: [Angiogenin: involvement in angiogenesis and tumour growth]. Bull Cancer. 2001;88:725–732.
  • Kadomatsu K, Tomomura M, Muramatsu T: cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun. 1988;151:1312–1318.
  • Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R: An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 1997;57:1814–1819.
  • Muramatsu H, Muramatsu T: Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem Biophys Res Commun. 1991;177:652–658.
  • Takada T, Toriyama K, Muramatsu H, Song XJ, Torii S, Muramatsu T: Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem. 1997;122:453–458.
  • Reynolds PR, Mucenski ML, Whitsett JA: Thyroid transcription factor (TTF)-1 regulates the expression of midkine (MK) during lung morphogenesis. Dev Dyn. 2003;227:227–237.
  • Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA: Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem. 2004;279:37124–37132.
  • Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE: CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37:137–148.
  • Adams JC, Lawler J: The thrombospondins. Int J Biochem Cell Biol. 2004;36:961–968.
  • Lawler J: The functions of thrombospondin-1 and -2. Curr Opin Cell Biol. 2000;12:634–640.
  • Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A. 1990;87:6624–6628.
  • Baenziger NL, Brodie GN, Majerus PW: Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem. 1972;247:2723–2731.
  • Corless CL, Mendoza A, Collins T, Lawler J: Colocalization of thrombospondin and syndecan during murine development. Dev Dyn. 1992;193:346–358.
  • Iruela-Arispe ML, Liska DJ, Sage EH, Bornstein P: Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev Dyn. 1993;197:40–56.
  • O’Shea KS, Dixit VM: Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol. 1988;107:2737–2748.
  • Patel MK, Lymn JS, Clunn GF, Hughes AD: Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:2107–2114.
  • Isenberg JS, Wink DA, Roberts DD: Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res. 2006;71:785–793.
  • Ren B, Yee KO, Lawler J, Khosravi-Far R: Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta. 2006;1765:178–188.
  • Wight TN, Raugi GJ, Mumby SM, Bornstein P: Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem. 1985;33:295–302.
  • Sage H, Farin FM, Striker GE, Fisher AB: Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry. 1983;22:2148–2155.
  • Yehualaeshet T, O’Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, Khalil N: Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol. 1999;155: 841–851.
  • Sozo F, Hooper SB, Wallace MJ: Thrombospondin-1 expression and localization in the developing ovine lung. J Physiol. 2007;584:625–635.
  • Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J: Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem. 1987;164:189–195.
  • Weyrich AS, Schwertz H, Kraiss LW, Zimmerman GA: Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost. 2009;7:241–246.
  • Belloc F, Heilmann E, Combrie R, Boisseau MR, Nurden AT: Protein synthesis and storage in human platelets: a defective storage of fibrinogen in platelets in Glanzmann's thrombasthenia. Biochim Biophys Acta. 1987;925:218–225.
  • Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, Delespesse G, Sarfati M: Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med. 2003;198:1277–1283.
  • Mandal RV, Mark EJ, Kradin RL: Megakaryocytes and platelet homeostasis in diffuse alveolar damage. Exp Mol Pathol. 2007;83:327–331.
  • Mostafa SS, Miller WM, Papoutsakis ET: Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol. 2000;111:879–889.
  • Segall M, Goetzman B: Hypoxic pulmonary hypertension: changes in platelet size and number. Am J Perinatol. 1991;8:300–303.
  • Barazzone C, Tacchini-Cottier F, Vesin C, Rochat AF, Piguet PF: Hyperoxia induces platelet activation and lung sequestration: an event dependent on tumor necrosis factor-alpha and CD11a. Am J Respir Cell Mol Biol. 1996;15: 107–114.
  • Yang J, Yang M, Xu F, Li K, Lee SK, Ng PC, Tam JS, Yuen PM, Fok TF: Effects of oxygen-induced lung damage on megakaryocytopoiesis and platelet homeostasis in a rat model. Pediatr Res. 2003;54:344–352.
  • Javerzat S, Franco M, Herbert J, Platonova N, Peille AL, Pantesco V, De Vos J, Assou S, Bicknell R, Bikfalvi A, Hagedorn M: Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system. PLoS One. 2009;4:e7856.
  • Favre CJ, Mancuso M, Maas K, McLean JW, Baluk P, McDonald DM: Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung. Am J Physiol Heart Circ Physiol. 2003;285:H1917–H1938.
  • Wallgard E, Larsson E, He L, Hellstrom M, Armulik A, Nisancioglu MH, Genove G, Lindahl P, Betsholtz C: Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. Arterioscler Thromb Vasc Biol. 2008;28:1469–1476.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.